Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases affecting ...

The Breakthrough Therapy designation is supported by positive interim data from the phase 2b VANTAGE study (ClinicalTrials.gov Identifier: NCT05050136) that evaluated the efficacy and safety of ...

Affiliate content. See how LeanBliss and SuperThin stack up against each other when it comes to weight loss support.

Analyst Ed Arce of H.C. Wainwright maintained a Buy rating on Mirum Pharmaceuticals (MIRM – Research Report), retaining the price target ...

Cutting-edge research has uncovered how chronic stress disrupts the balance of gut microbiota to speed up the progression of ...

The study’s results, set to be presented on Sunday at a scientific meeting of the United European Gastroenterology in Vienna, ...

The grape season is fleeting and abundant, delighting us from August to October. Why make the most of it? There's much more to grapes than their sweet taste: they're packed with valuable health ...

The market for NASH drugs is expected to exceed $1 billion ... The most advanced investigational compound is a potent, non-bile acid FXR agonist, which recently received fast track designation ...

October 2024, Vienna, Austria) Cutting-edge research has uncovered how chronic stress disrupts the balance of gut microbiota to speed up the ...

Cutting-edge research has uncovered how chronic stress disrupts the balance of gut microbiota to speed up the progression of colorectal cancer (CRC), opening new avenues for CRC prevention and ...

You might have targeted or immunotherapy drugs for advanced bile duct cancer. This is cancer that has grown into the lymph nodes or organs near the bile duct such as the liver or small bowel. Or that ...